[Skip to Content]
Claim CME
Infectious Diseases

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

Educational Objective
To identify the key insights or developments described in this podcast
0.25 Credit CME
JAMA
January 6, 2021 Audio Clinical Review 16 min 19 sec

MOC/CME Information

Listen Claim CME
<title>COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions</title>
Backward 15 Play Pause Forward 15
1x
0:00 / 0:00
Download MP3

Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23, 2020.

Sign in to take quiz and track your certificates

Subscribe

Subscribe on your favorite podcast source to receive future episodes of this podcast.
Learn more about this JAMA Network podcast here

Related Articles

  1. Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US
    1.00 CME

  2. Anaphylaxis After First Dose of the Pfizer-BioNTech COVID-19 Vaccination
    1.00 CME

  3. Anaphylaxis After Vaccination for COVID-19 in the US
    1.00 CME

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

See More About

Allergy and Clinical Immunology Infectious Diseases Vaccination Regulatory Agencies Public Health Coronavirus (COVID-19)
Close
Close
Close

Name Your Search

Save Search
Privacy Policy|Terms of Use
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue